ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
Product List
Home / ARPOD-CV DRY SYP
ARPOD-CV DRY SYP

EXOFEX-D

Product Packing: 100 ML

Product Composition: Dextromethorphan + Chlorpheneramine maleate + Phenylephrine HCL

Product Price: MRP : 107

EXOFEX-D JUNIOR Syrup

Dextromethorphan 10 mg + Chlorpheniramine Maleate (CPM) 2 mg + Phenylephrine 5 mg | SYP 60 ML

EXOFEX-D JUNIOR is an oral cough-and-cold combination syrup containing Dextromethorphan, Chlorpheniramine Maleate (CPM) and Phenylephrine as the declared ingredient strengths. Dextromethorphan is an antitussive, CPM is a first-generation H1 antihistamine, and Phenylephrine is an alpha-adrenergic decongestant.

The formulation combines cough suppression, antihistamine action and nasal-decongestant action for selected symptomatic cough-and-cold conditions where this fixed-dose combination is approved and clinically appropriate. Pediatric use must follow the current approved age range, exact concentration per measured volume and professional guidance.

Composition

Each labelled dose contains:

·         Dextromethorphan - 10 mg

·         Chlorpheniramine Maleate (CPM) - 2 mg + Phenylephrine - 5 mg

·         Syrup base / excipients - q.s. Exact ingredient strength per ml or measured dose must be verified from the approved product label.

Dosage form: Oral Syrup

Pack size: 60 ml

Uses of EXOFEX-D JUNIOR

EXOFEX-D JUNIOR may be prescribed for short-term symptomatic relief of selected cough-and-cold symptoms where this combination is approved and age-appropriate.

·         Dextromethorphan helps suppress troublesome dry or non-productive cough

·         CPM helps reduce histamine-mediated symptoms such as sneezing and runny nose

·         Phenylephrine provides nasal-decongestant action by constricting blood vessels in the nasal mucosa

·         The combined formulation may provide multi-symptom relief when specifically indicated by a healthcare professional

Cough in children can have many causes. Persistent cough, breathing difficulty, wheezing, high fever, dehydration, bluish lips, unusual drowsiness or other concerning symptoms require prompt medical evaluation.

How EXOFEX-D JUNIOR Works

EXOFEX-D JUNIOR combines three pharmacological actions:

Dextromethorphan: Acts centrally to suppress the cough reflex and is used for selected non-productive cough symptoms.

Chlorpheniramine Maleate (CPM): Blocks H1 histamine receptors, helping reduce sneezing, runny nose and other allergy-related symptoms; it may cause drowsiness and anticholinergic effects.

Phenylephrine: Stimulates alpha-adrenergic receptors, causing vasoconstriction in nasal mucosa and helping reduce nasal congestion.

The combination provides symptomatic relief only and does not treat every underlying cause of cough, cold or respiratory symptoms.

Use should be limited to the approved indication, age group, dose and duration recommended by the treating healthcare professional.

 

Dosage and Direction for Use

Use EXOFEX-D JUNIOR exactly according to the approved product label or prescriber's directions. The supplied brief does not state the measured volume to which the listed strengths apply, so verify the exact concentration before calculating or administering a dose.

Measure each dose accurately with a calibrated oral syringe, cup or other appropriate measuring device. Do not use an ordinary household spoon.

Do not exceed the prescribed dose or frequency and do not combine with another cough/cold product containing Dextromethorphan, antihistamines or decongestants unless specifically advised.

Pediatric cough-and-cold medicines require age-specific caution. Use only within the current approved pediatric age range and under appropriate professional guidance.

Possible Side Effects

Possible unwanted effects may include:

·         Drowsiness, dizziness, dry mouth, blurred vision, constipation or urinary difficulty associated with CPM

·         Nausea, stomach discomfort or dizziness may occur with Dextromethorphan

·         Phenylephrine may cause nervousness, restlessness, headache, palpitations or increased blood pressure

·         Rare but serious effects can include severe hypersensitivity, marked blood-pressure or heart-rhythm changes, or serotonin syndrome when Dextromethorphan is combined with certain serotonergic medicines

·         Seek urgent medical attention for breathing difficulty, facial swelling, severe rash, fainting, severe palpitations, marked agitation, confusion, muscle rigidity or suspected overdose.

Persistent or troublesome adverse effects should be discussed with a healthcare professional.

Precautions and Contraindications

Before using EXOFEX-D JUNIOR, review the child's age, cough characteristics, respiratory history, blood pressure/cardiovascular conditions, thyroid disease, glaucoma, urinary problems and all concomitant medicines.

·         CPM may cause sedation and anticholinergic effects. Extra caution is required with sedatives, alcohol exposure, glaucoma, urinary retention and other anticholinergic medicines.

·         Phenylephrine requires caution in hypertension, cardiovascular disease, hyperthyroidism and patients using medicines that can significantly increase adrenergic effects.

·         Dextromethorphan can interact seriously with monoamine oxidase inhibitors (MAOIs) and certain serotonergic medicines. Follow the current label regarding required avoidance periods.

·         Do not use duplicate cough/cold products containing Dextromethorphan, antihistamines or decongestants unless specifically directed.

·         Do not use prolonged or recurrent cough, asthma-related cough, cough with substantial mucus, or serious respiratory symptoms for self-treatment without appropriate clinical evaluation.

·         Children with significant chronic disease or those taking multiple medicines require individualized professional guidance.

·         Keep out of reach of children and store according to the approved pack instructions.

·         Drug Interaction Considerations

·         Important interaction considerations include MAO inhibitors, serotonergic medicines, sedatives/CNS depressants, other antihistamines, decongestants and medicines that affect blood pressure or heart rate.

·         Caregivers should provide the healthcare professional with a complete list of prescription medicines, OTC cough/cold products, vitamins and supplements before use.

Business Growth Opportunity with EXOFEX-D JUNIOR

EXOFEX-D JUNIOR offers pharmaceutical distributors and healthcare entrepreneurs an opportunity to add a Dextromethorphan + CPM + Phenylephrine oral syrup in a convenient 60 ml pack to their cough-and-cold portfolio.

Cough-and-cold symptom management is an established healthcare segment. Promotion and use should remain consistent with approved pediatric indications, responsible prescribing, ethical pharmaceutical practice and applicable regulations.

 

Key Business Advantages

·         Three-component cough-and-cold formulation

·         Dextromethorphan 10 mg + CPM 2 mg + Phenylephrine 5 mg

·         Antitussive + antihistamine + nasal-decongestant combination

·         Convenient 60 ml oral syrup pack

·         Suitable addition to cough-and-cold portfolios where the fixed-dose combination is approved and age-appropriate

·         Opportunity for ethical promotion through appropriate healthcare channels

PCD Pharma Franchise Opportunity for EXOFEX-D JUNIOR

Ethics Medinova Private Limited offers PCD Pharma Franchise opportunities for EXOFEX-D JUNIOR in selected territories across India, subject to availability, applicable regulations and mutually agreed business terms.

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

 

Franchise Support May Include

·         Monopoly-based territory opportunities, subject to availability

·         Promotional materials and visual aids

·         Product information and marketing support

·         Reliable supply coordination

·         Access to a growing pharmaceutical product portfolio

·         Professional partner assistance

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for EXOFEX-D JUNIOR and other quality-focused healthcare products.

Third-Party Manufacturing Support for Dextromethorphan + CPM + Phenylephrine Syrup

Ethics Medinova also supports eligible businesses exploring third-party manufacturing of formulations similar to EXOFEX-D JUNIOR under their own brand, subject to applicable licensing, pediatric formulation, regulatory and manufacturing requirements.

Our third-party manufacturing support may include:

·         Customized product and pack requirements, subject to regulatory feasibility

·         Private-label manufacturing opportunities

·         Customized packaging and branding support

·         Product label and pack configuration assistance

·         Manufacturing coordination through suitable licensed facilities

·         Support for documentation and applicable regulatory requirements

This service may be suitable for eligible pharmaceutical companies and healthcare brands seeking to expand a cough-and-cold oral-liquid portfolio.

Frequently Asked Questions About EXOFEX-D JUNIOR

1. What is EXOFEX-D JUNIOR?

EXOFEX-D JUNIOR is a 60 ml oral syrup containing Dextromethorphan 10 mg, CPM 2 mg and Phenylephrine 5 mg as the supplied strength statement.

2. What is EXOFEX-D JUNIOR used for?

It may be prescribed for short-term symptomatic relief of selected cough-and-cold symptoms where this combination is approved, age-appropriate and clinically indicated.

3. How should EXOFEX-D JUNIOR be measured?

Use a calibrated oral measuring device and follow the exact prescribed volume. The current approved label should be checked for the ingredient concentration per measured dose.

4. Can CPM cause drowsiness?

Yes. Chlorpheniramine is a first-generation antihistamine and can cause drowsiness, dizziness, dry mouth and other anticholinergic effects.

5. What precautions apply to Phenylephrine?

Phenylephrine can increase blood pressure or cause palpitations and requires caution in hypertension, cardiovascular disease and hyperthyroidism.

6. What important interaction applies to Dextromethorphan?

Dextromethorphan can interact with MAO inhibitors and serotonergic medicines and may increase the risk of serious reactions including serotonin syndrome.

7. Is a PCD Pharma Franchise available for EXOFEX-D JUNIOR?

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

8. Can this formulation be manufactured under my own brand?

Eligible businesses interested in a similar Dextromethorphan + CPM + Phenylephrine syrup may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable licensing and regulatory requirements.

Disclaimer

EXOFEX-D JUNIOR product information in this document is for general professional and business information. The supplied product brief states Dextromethorphan 10 mg + CPM 2 mg + Phenylephrine 5 mg, SYP 60 ML, but does not specify the measured volume to which these strengths apply. Exact composition, concentration, approved pediatric age range, indications, dosage, dose interval, maximum dose, contraindications, warnings, interactions, administration instructions, excipients and regulatory status must be verified against the current approved product label before manufacture, promotion, prescribing, dispensing or use. Pediatric cough-and-cold combinations require particular age-specific caution. This document is not a substitute for professional medical advice.

Contact